Frankfurt Stock Exchange · Healthcare
Invest in Arzneiwerk AG VIDA stock from India
Indian and foreign residents can buy Arzneiwerk AG VIDA (TLIK) shares directly through Paasa.
By Paasa · Updated
Arzneiwerk AG VIDA at a glance
- Price
- €0.13-€0.16 (54.86%)
- Market cap
- €780.94K
- Day range
- €0.13 – €0.13
- P/E
- -1.76
- Dividend yield
- None
- Volume
- 34.00
- 1 month
- -36.27%
- 6 months
- -50.38%
- YTD
- -66.67%
- 1 year
- -70.45%
- 5 years
- -93.81%
Arzneiwerk AG VIDA statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €68.5K | €657.5K | €1.7M | €2.2M | €2.7M |
| Gross profit | €66.1K | €657.5K | €1.5M | €1.9M | €2.2M |
| Operating income | −€503.8K | −€602.0K | −€1.8M | −€1.5M | −€232.6K |
| Net income | −€563.8K | −€835.2K | −€1.9M | −€1.7M | −€267.5K |
| Earnings per share | −€0.09 | −€0.13 | −€0.30 | −€0.27 | −€0.04 |
| EBITDA | −€501.4K | −€661.2K | −€1.8M | −€1.9M | −€237.8K |
| Total assets | €1.6M | €4.2M | €3.3M | €1.9M | €2.8M |
| Total debt | €3.7M | €636.0K | €125.0K | €0.0 | €0.0 |
| Cash and short-term investments | €21.9K | €125.5K | €82.1K | €42.0K | €391.2K |
| Shareholders' equity | −€2.9M | €0.0 | €0.0 | €379.2K | €1.6M |
| Operating cash flow | −€664.7K | −€1.4M | −€1.1M | −€9.0K | −€280.6K |
| Free cash flow | €0.0 | −€1.4M | −€1.1M | −€961.0K | −€330.3K |
| Capital expenditure | €664.7K | −€525.0 | €0.0 | −€952.0K | −€49.7K |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in EUR; a dash means the provider reported nothing for that line.
How to invest in Arzneiwerk AG VIDA from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search TLIK and buy
Find Arzneiwerk AG VIDA by name or by its ticker, TLIK, and place your order.
Why invest in Arzneiwerk AG VIDA from India
What Arzneiwerk AG VIDA does
Established in 1996, Arzneiwerk AG VIDA serves as a European supplier of pharmaceutical products, with a particular focus on novel and scarce medical treatments. In July 2024, the organization underwent a name change, adopting its current identity from its former designation as TELES Aktiengesellschaft. Arzneiwerk AG VIDA operates in the Medical - Distribution industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Arzneiwerk AG VIDA stock from India?
Yes. Indian residents and NRIs can buy Arzneiwerk AG VIDA (TLIK) shares directly through Paasa. Arzneiwerk AG VIDA is listed on the Frankfurt Stock Exchange, in the Medical - Distribution industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Arzneiwerk AG VIDA shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.